vs

Side-by-side financial comparison of P3 Health Partners Inc. (PIII) and Symbotic Inc. (SYM). Click either name above to swap in a different company.

Symbotic Inc. is the larger business by last-quarter revenue ($630.0M vs $384.8M, roughly 1.6× P3 Health Partners Inc.). Symbotic Inc. runs the higher net margin — 0.4% vs -19.6%, a 20.0% gap on every dollar of revenue. On growth, Symbotic Inc. posted the faster year-over-year revenue change (29.4% vs 3.8%). Over the past eight quarters, Symbotic Inc.'s revenue compounded faster (21.9% CAGR vs -0.5%).

P3 Health Partners Inc. is a population health management and value-based care services firm operating primarily in the United States. It partners with primary care providers and health systems to deliver coordinated, high-quality care for patient populations, especially Medicare Advantage beneficiaries, focusing on improving health outcomes and lowering unnecessary healthcare costs.

Symbotic Inc. is an American robotics warehouse automation company based in Wilmington, Massachusetts.

PIII vs SYM — Head-to-Head

Bigger by revenue
SYM
SYM
1.6× larger
SYM
$630.0M
$384.8M
PIII
Growing faster (revenue YoY)
SYM
SYM
+25.6% gap
SYM
29.4%
3.8%
PIII
Higher net margin
SYM
SYM
20.0% more per $
SYM
0.4%
-19.6%
PIII
Faster 2-yr revenue CAGR
SYM
SYM
Annualised
SYM
21.9%
-0.5%
PIII

Income Statement — Q4 FY2025 vs Q1 FY2026

Metric
PIII
PIII
SYM
SYM
Revenue
$384.8M
$630.0M
Net Profit
$-75.5M
$2.6M
Gross Margin
21.2%
Operating Margin
-40.0%
1.0%
Net Margin
-19.6%
0.4%
Revenue YoY
3.8%
29.4%
Net Profit YoY
-28.8%
174.9%
EPS (diluted)
$-23.08
$0.02

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PIII
PIII
SYM
SYM
Q4 25
$384.8M
$630.0M
Q3 25
$345.3M
$618.5M
Q2 25
$355.8M
$592.1M
Q1 25
$373.2M
$549.7M
Q4 24
$370.7M
$486.7M
Q3 24
$362.1M
$503.6M
Q2 24
$379.2M
$491.9M
Q1 24
$388.5M
$424.3M
Net Profit
PIII
PIII
SYM
SYM
Q4 25
$-75.5M
$2.6M
Q3 25
$-31.6M
$-3.6M
Q2 25
$-20.4M
$-5.9M
Q1 25
$-20.5M
$-3.9M
Q4 24
$-58.6M
$-3.5M
Q3 24
$-46.5M
$-2.5M
Q2 24
$-12.0M
$-2.5M
Q1 24
$-18.7M
$-6.6M
Gross Margin
PIII
PIII
SYM
SYM
Q4 25
21.2%
Q3 25
20.6%
Q2 25
18.2%
Q1 25
19.6%
Q4 24
16.4%
Q3 24
12.7%
Q2 24
13.7%
Q1 24
10.4%
Operating Margin
PIII
PIII
SYM
SYM
Q4 25
-40.0%
1.0%
Q3 25
-12.8%
-3.5%
Q2 25
-9.6%
-6.2%
Q1 25
-10.2%
-5.8%
Q4 24
-37.4%
-5.1%
Q3 24
-29.5%
-4.3%
Q2 24
-8.3%
-5.1%
Q1 24
-11.3%
-12.0%
Net Margin
PIII
PIII
SYM
SYM
Q4 25
-19.6%
0.4%
Q3 25
-9.1%
-0.6%
Q2 25
-5.7%
-1.0%
Q1 25
-5.5%
-0.7%
Q4 24
-15.8%
-0.7%
Q3 24
-12.8%
-0.5%
Q2 24
-3.2%
-0.5%
Q1 24
-4.8%
-1.6%
EPS (diluted)
PIII
PIII
SYM
SYM
Q4 25
$-23.08
$0.02
Q3 25
$-9.67
$-0.04
Q2 25
$-6.23
$-0.05
Q1 25
$-6.28
$-0.04
Q4 24
$-23.13
$-0.03
Q3 24
$-15.70
$-0.03
Q2 24
$-7.37
$-0.02
Q1 24
$-7.86
$-0.07

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PIII
PIII
SYM
SYM
Cash + ST InvestmentsLiquidity on hand
$25.0M
$1.8B
Total DebtLower is stronger
$228.4M
Stockholders' EquityBook value
$-155.2M
$663.8M
Total Assets
$656.6M
$3.0B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PIII
PIII
SYM
SYM
Q4 25
$25.0M
$1.8B
Q3 25
$37.7M
$1.2B
Q2 25
$38.6M
$777.6M
Q1 25
$40.1M
$954.9M
Q4 24
$38.8M
$903.0M
Q3 24
$63.0M
$727.3M
Q2 24
$73.1M
$870.5M
Q1 24
$27.3M
$901.4M
Total Debt
PIII
PIII
SYM
SYM
Q4 25
$228.4M
Q3 25
$252.8M
Q2 25
$182.0M
Q1 25
$171.1M
Q4 24
$108.9M
Q3 24
$133.2M
Q2 24
$133.1M
Q1 24
$118.1M
Stockholders' Equity
PIII
PIII
SYM
SYM
Q4 25
$-155.2M
$663.8M
Q3 25
$-18.7M
$221.3M
Q2 25
$44.5M
$210.8M
Q1 25
$63.3M
$205.4M
Q4 24
$75.9M
$196.5M
Q3 24
$120.5M
$197.2M
Q2 24
$166.8M
$418.7M
Q1 24
$146.6M
$417.1M
Total Assets
PIII
PIII
SYM
SYM
Q4 25
$656.6M
$3.0B
Q3 25
$683.6M
$2.4B
Q2 25
$731.6M
$1.8B
Q1 25
$783.9M
$2.0B
Q4 24
$783.4M
$1.7B
Q3 24
$833.3M
$1.6B
Q2 24
$892.8M
$1.6B
Q1 24
$855.9M
$1.6B
Debt / Equity
PIII
PIII
SYM
SYM
Q4 25
Q3 25
Q2 25
4.09×
Q1 25
2.71×
Q4 24
1.43×
Q3 24
1.11×
Q2 24
0.80×
Q1 24
0.81×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PIII
PIII
SYM
SYM
Operating Cash FlowLast quarter
$-25.7M
$191.5M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
Cash ConversionOCF / Net Profit
73.61×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PIII
PIII
SYM
SYM
Q4 25
$-25.7M
$191.5M
Q3 25
$-15.4M
$530.7M
Q2 25
$-16.6M
$-138.3M
Q1 25
$-33.5M
$269.6M
Q4 24
$-57.2M
$205.0M
Q3 24
$-22.6M
$-99.4M
Q2 24
$-10.2M
$50.4M
Q1 24
$-20.0M
$21.1M
Free Cash Flow
PIII
PIII
SYM
SYM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
$197.7M
Q3 24
$-120.1M
Q2 24
$33.5M
Q1 24
$18.6M
FCF Margin
PIII
PIII
SYM
SYM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
40.6%
Q3 24
-23.9%
Q2 24
6.8%
Q1 24
4.4%
Capex Intensity
PIII
PIII
SYM
SYM
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
0.0%
1.5%
Q3 24
0.0%
4.1%
Q2 24
0.0%
3.4%
Q1 24
0.0%
0.6%
Cash Conversion
PIII
PIII
SYM
SYM
Q4 25
73.61×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PIII
PIII

Capitated Revenue$366.2M95%
Health Care Patient Service$18.6M5%
Health Care Care Coordination Management Fees$2.7M1%

SYM
SYM

Systems$590.3M94%
Operation Services$28.8M5%
Software Maintenance And Support$10.9M2%
Revision Of Prior Period Change In Accounting Principle Adjustment$2.9M0%
Related Party$1.1M0%

Related Comparisons